Semiconductor Manufacturing
Axcelis Technologies
A US-based maker of ion implantation equipment, a specialized process step in semiconductor manufacturing used to precisely modify the electrical properties of silicon wafers. Axcelis Technologies reported full-year 2025 revenue of $839.0 million (98.2% from its ion implantation business) with operating profit of $119.3 million (down from $210.8 million in 2024); power-device-focused ion implantation represented 55% of the value of 2025 system shipments, with Wall Street projecting growth resuming to an estimated $921 million in 2027.
Leading Indicators
Hiring and patent filing trends — the underlying numbers Momentum is computed from. Insider filing activity is tracked separately under Sources below.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
3 sources · 1 government/SEC filing · 84% avg. source confidence
- U.S. Securities and Exchange Commission (EDGAR) — Axcelis Technologies, Inc. FY2025 Annual Report (Form 10-K), filed with the SEC95% source confidence
- SEC 10-K filing / Motley Fool analysis — Axcelis reports $839M in 2025 revenue, with ion implantation representing 98% of sales78% source confidence
- SEC 10-K filing (FY2025) — Axcelis' power-device implant systems accounted for 55% of 2025 system shipment value80% source confidence
Insider Filing Activity
Counts filing frequency only — transaction direction/size wasn't parseable from the sampled filings · sourced from SEC EDGAR · as of Jul 28, 2026
Dependency Map
What Axcelis Technologies depends on below, and who depends on Axcelis Technologies above — click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far (last 6 months)
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.